Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Electroporation therapy results in at least 80% reduction in tumor volume in preclinical studies

Feb. 25, 1998

Diversa receives NCI grant for pharmaceutical research

Feb. 24, 1998

CellPro to begin clinical evaluation of B-Cell Depletion System

Feb. 24, 1998

MedImmune licenses novel antibacterial technology to Siga

Feb. 19, 1998

Meridian and Duoject to jointly develop innovative drug delivery system

Feb. 18, 1998

Diversa identifies new therapeutic leads on the ocean floor

Feb. 18, 1998

CellPro: Q3 1998 highlights

Feb. 18, 1998

SIDDCO expands combinatorial chemistry consortium

Feb. 17, 1998

Lead compounds identified in Warner-Lambert/Trega collaboration

Feb. 17, 1998

NanoSystems to develop new formulation of Boehringer Ingelheim drug

Feb. 17, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...